• Markets
    • icon
  • Companies
4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.52

 -0.005 (-0.962%)
ASX:Live
26/07/2024 04:10:15 PM
Near Support Hammer Bearish HALO Ords HALO Earnings Momentum GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

4DX Overview

4DX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About 4DX

Website

4DMedical Ltd

Telephone

61.3.9545.5940

Address

700 Swanston Street Level 7 Carlton, Victoria (VIC) 3053

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$217.58M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.45 - 1.1

Trade Value (12mth)

AU$121,087.00

1 week

-1.89%

1 month

-6.31%

YTD

-27.27%

1 year

-25.18%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

26.400%

EBITDA Margin

%

Operating Cashflow

-$23m

Free Cash Flow Return

-32.30%

ROIC

-44.80%

Interest Coverage

-142.90

Quick Ratio

4.60

Other Data

Shares on Issue (Fully Dilluted)

372m

HALO Sector

Technology

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.02

4DX Announcements

Latest Announcements

Date Announcements

11 July 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

08 July 24

4DMedical expands with Jones Radiology contract

×

4DMedical expands with Jones Radiology contract

28 June 24

4DMedical secures At-the-Market funding facility

×

4DMedical secures At-the-Market funding facility

28 June 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

28 June 24

Cleansing Notice

×

Cleansing Notice

21 June 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

09 May 24

4DMedical gains US CMS reimbursement for CT LVAS

×

4DMedical gains US CMS reimbursement for CT LVAS

09 May 24

Market update on recent developments

×

Market update on recent developments

07 May 24

4DMedical signs research agreement with West Los Angeles VA

×

4DMedical signs research agreement with West Los Angeles VA

03 May 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

30 April 24

Quarterly Activity Report and Appendix 4C for Q3 FY2024

×

Quarterly Activity Report and Appendix 4C for Q3 FY2024

19 April 24

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

19 April 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

05 April 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

20 March 24

Notification regarding unquoted securities - 4DX

×

Notification regarding unquoted securities - 4DX

11 March 24

U.S. budget pushes for action on screening for Veterans

×

U.S. budget pushes for action on screening for Veterans

08 March 24

Application for quotation of securities - 4DX

×

Application for quotation of securities - 4DX

08 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

08 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

08 March 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

08 March 24

Cleansing Notice

×

Cleansing Notice

01 March 24

4DMedical secures participation in pivotal burn pit research

×

4DMedical secures participation in pivotal burn pit research

01 March 24

S&P DJI Announces March 2024 Quarterly Rebalance

×

S&P DJI Announces March 2024 Quarterly Rebalance

28 February 24

Appendix 4D and Half-Year Report

×

Appendix 4D and Half-Year Report

28 February 24

4DMedical reports positive 1H FY2024 results

×

4DMedical reports positive 1H FY2024 results

4DX Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.08 -0.08 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.08 -0.08 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.3 -2.0 -25.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.06 -0.08 -0.08 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.09 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.8 -17.6 -4.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -4.7 -16.1 -11.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.28 0.20 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.27 0.18 0.19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 574.0 -31.5 4.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 261 295 300 Lock Lock Lock
Basic m Lock Lock Lock Lock 261 295 300 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -82.4 385.9 -31.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 16 20 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -12 -20 -24 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.1 -69.6 -18.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -5,551.4 -1,937.8 -3,378.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 5,651 2,038 3,479 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -24 -35 -42 Lock Lock Lock
     Growth % Lock Lock Lock Lock -53.5 -49.4 -19.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -10,875.4 -3,343.9 -5,845.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -24 -37 -45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -52.5 -51.0 -21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11,217.2 -3,485.8 -6,202.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -25 -28 -37 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -4 -4 -5 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -21 -25 -31 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.5 -14.8 -27.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9,872.2 -2,332.6 -4,378.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -15 -25 -23 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 4 2 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -4 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 88 -1 43 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -15 -28 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock -89.3 -84.9 17.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -69.6 -26.5 -32.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 81 51 70 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 93 74 93 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 5 4 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -79 -45 -64 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 9 15 21 Lock Lock Lock
Equity $m Lock Lock Lock Lock 83 60 71 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 84 65 76 Lock Lock Lock
     Growth % Lock Lock Lock Lock 853.6 -23.3 17.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -23.1 -33.1 -33.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -54.3 -48.7 -62.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -58.6 -33.0 -44.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -39.7 -33.9 -32.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -8.8 -196.3 -142.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.4 1.3 1.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -95.0 -75.4 -90.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 10.5 6.2 4.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 10.5 6.2 4.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 94.2 86.8 88.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -177.8 -264.4 -132.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.1 0.2 0.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 144.8 277.4 75.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 206.6 171.7 398.6 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -11,740.8 -2,666.9 -5,093.9 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -27.5 -37.8 -39.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -23.1 -33.1 -33.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.2 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -25.7 -41.3 -44.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 2.5 1.3 4.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 4,828.0 1,792.8 3,385.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 4,830.5 1,794.1 3,390.2 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 31.1 19.3 33.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 4,799.4 1,774.8 3,356.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.02%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.10%

3 Month Change

-0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.52.
The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$1.10.
The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.45.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) does not pay a dividend.
4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.
4DMedical Ltd (4DX:ASX) is classified in the Technology.
The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.